Michel Mikhail
2021
In 2021, Michel Mikhail earned a total compensation of $153.1K as Chief Regulatory Officer at Navidea Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $15,053 |
|---|---|
| Option Awards | $81,580 |
| Salary | $56,250 |
| Other | $167 |
| Total | $153,050 |
Mikhail received $81.6K in option awards, accounting for 53% of the total pay in 2021.
Mikhail also received $15.1K in non-equity incentive plan, $56.3K in salary and $167 in other compensation.
Rankings
In 2021, Michel Mikhail's compensation ranked 12,103rd out of 12,397 executives tracked by ExecPay. In other words, Mikhail earned more than 2.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,103 out of 12,397 | 2nd |
Division Manufacturing | 5,353 out of 5,492 | 3rd |
Major group Chemicals And Allied Products | 2,326 out of 2,367 | 2nd |
Industry group Drugs | 2,053 out of 2,090 | 2nd |
Industry In Vitro and In Vivo Diagnostic Substances | 59 out of 61 | 3rd |
Source: SEC filing on October 24, 2022.
Mikhail's colleagues
We found four more compensation records of executives who worked with Michel Mikhail at Navidea Biopharmaceuticals in 2021.
2021
Jed Latkin
Navidea Biopharmaceuticals
Chief Executive Officer
2021
Michael Rosol
Navidea Biopharmaceuticals
Chief Medical Officer
2021
Erika Eves
Navidea Biopharmaceuticals
Vice President, Finance & Administration
2021
Joel Kaufman
Navidea Biopharmaceuticals